Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Naproxen may help prevent or lessen bone pain caused by pegfilgrastim. It is not
yet known whether naproxen is more effective than a placebo in preventing bone pain caused by
pegfilgrastim in patients with non-hematologic cancer undergoing chemotherapy.
PURPOSE: This randomized phase III trial is studying naproxen to see how well it works
compared with a placebo in preventing bone pain caused by pegfilgrastim in patients with
non-hematologic cancer undergoing chemotherapy.